Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing

Authors:
Nuñez JK, Chen J, Pommier GC, Cogan JZ, Replogle JM, Adriaens C, Ramadoss GN, Shi Q, Hung KL, Samelson AJ, Pogson AN, Kim JYS, Chung A, Leonetti MD, Chang HY, Kampmann M, Bernstein BE, Hovestadt V, Gilbert LA, Weissman JS
In:
Source: Cell Res
Publication Date: (2021)
Issue: 184(9): 2503-2519.e17
Research Area:
Cancer Research/Cell Biology
Cells used in publication:
HeLa
Species: human
Tissue Origin: cervix
Platform:
4D-Nucleofector® 96-well Systems
Experiment

CRISPRoff experiments in HeLa and U2OS cells were performed by nucleofection of plasmids using the SE. Cell Line 96-well Nucleofector Kit (Lonza) and a 96-well ShuttleTM Device (Lonza), per manufacturer protocol. Substrate: 300 ng of plasmid encoding CRISPRoff, dCas9-KRAB, or dCas9-D3A-3L and 150 ng of plasmids encoding sgRNAs. 

Abstract

A general approach for heritably altering gene expression has the potential to enable many discovery and therapeutic efforts. Here, we present CRISPRoff-a programmable epigenetic memory writer consisting of a single dead Cas9 fusion protein that establishes DNA methylation and repressive histone modifications. Transient CRISPRoff expression initiates highly specific DNA methylation and gene repression that is maintained through cell division and differentiation of stem cells to neurons. Pairing CRISPRoff with genome-wide screens and analysis of chromatin marks establishes rules for heritable gene silencing. We identify single guide RNAs (sgRNAs) capable of silencing the large majority of genes including those lacking canonical CpG islands (CGIs) and reveal a wide targeting window extending beyond annotated CGIs. The broad ability of CRISPRoff to initiate heritable gene silencing even outside of CGIs expands the canonical model of methylation-based silencing and enables diverse applications including genome-wide screens, multiplexed cell engineering, enhancer silencing, and mechanistic exploration of epigenetic inheritance.